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Abstract: Living organisms are constantly threatened by environmental DNA-damaging agents, including UV and ioniz-
ing radiation (IR). Repair of various forms of DNA damage caused by IR is normally thought to follow lesion-specific re-
pair pathways with distinct enzymatic machinery. DNA double strand break is one of the most serious kinds of damage 
induced by IR, which is repaired through double strand break (DSB) repair mechanisms, including homologous recombi-
nation (HR) and non-homologous end joining (NHEJ). However, recent studies have presented increasing evidence that 
various DNA repair pathways are not separated, but well interlinked. It has been suggested that non-DSB repair mecha-
nisms, such as Nucleotide Excision Repair (NER), Mismatch Repair (MMR) and cell cycle regulation, are highly involved 
in DSB repairs. These findings revealed previously unrecognized roles of various non-DSB repair genes and indicated that 
a successful DSB repair requires both DSB repair mechanisms and non-DSB repair systems. One of our recent studies 
found that suppressed expression of non-DSB repair genes, such as XPA, RPA and MLH1, influenced the yield of IR-
induced micronuclei formation and/or chromosome aberrations, suggesting that these genes are highly involved in DSB 
repair and DSB-related cell cycle arrest, which reveals new roles for these gene products in the DNA repair network. In 
this review, we summarize current progress on the function of non-DSB repair-related proteins, especially those that par-
ticipate in NER and MMR pathways, and their influence on DSB repair. In addition, we present our developing view that 
the DSB repair mechanisms are more complex and are regulated by not only the well known HR/NHEJ pathways, but also 
a systematically coordinated cellular network.  
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INTRODUCTION 
  Environmental DNA-damaging agents, including ultra-
violet (UV) and ionizing radiation (IR), are constant threats 
causing DNA damage in living organisms. There are differ-
ent forms of DNA damage, including double-strand break 
(DSB), as well as other types of damages such as hydrolytic 
depurination, apyrimidinic sites, and oxidative damage to the 
bases and the phosphodiester backbone of DNA. Repairs of 
different types of DNA damage are believed to follow le-
sion-specific repair pathways, such as DSB repair, nucleo-
tide excision repair (NER), mismatch repair (MMR), or base 
excision repair (BER) [1]. Specific groups of proteins from 
these pathways recognize DNA damage sites, and repair and 
induce cell cycle checkpoints. After sensing a genotoxic 
agent-induced primary DNA damage, a series of signal 
transduction cascades are initiated that are responsible for 
arresting the damaged cells at the cell cycle checkpoints, 
maintaining cellular homeostasis, and sending signals to in-
teract with neighboring cells. For example, early responses 
to DNA damage caused by IR are the activations of protein 
kinases ATM/ATR (ataxia telangiectasia mutated/ Rad3-
related) and the downstream p53 signaling pathway [2-4].   
 
*Address correspondence to this author at the Human Adaptation and Coun-
termeasures Division, NASA Johnson Space Center, Mail Code SK, 2101 
NASA Parkway, Houston, TX 77058, USA; Tel: (281) 483-9282; Fax: 
(281) 483-3789; E-mail: Ye.Zhang-1@nasa.gov 
Subsequently, transcriptional regulation of various genes and 
post-translational modification of proteins involved in DNA 
damage sensing, repair, and cell cycle regulation occur so 
that additional cascades of signaling pathways are initiated 
[5, 6].  
  Among all types of DNA damage, DSB is the most seri-
ous form that affects both strands of the DNA duplex. DSB 
is the major DNA damage induced by IR, including gamma 
and X- rays, although it does cause other minor damage to 
DNA [7]. Some chemotherapy drugs, such as bleomycin, 
mitoxantrone, amsacrine and etoposide, induce DSBs as well 
[8-10]. DSBs make cells more prone to unsuccessful DNA 
repair due to the lack of a complementary template, espe-
cially in G1 phase cells. Unrepaired DNA damage may cause 
cell cycle arrest and apoptosis; however, the accumulation of 
misrepairs may lead to chromosome instability and carcino-
genesis. The two distinct pathways for DSB repair that have 
been identified are homologous recombination (HR) and 
non-homologous end joining (NHEJ), serving in two differ-
ent scenarios [11-13]. DSB repair through HR requires the 
homologous sister chromatid or homologous chromosome, 
which only appears in late S/G2 phase, resulting in the error 
free restoration of the missing information to the damaged 
DNA [12]. However, in G1/early S-phase, the NHEJ path-
way may contribute the most to DSB repair. This can lead to 
an error prone repair due to its joining of the two ends of 
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cess of DNA repair through these two mechanisms requires 
the same Rad50-MRE11-NBS1 complex with two distinct 
groups of proteins, which have been studied for decades.  
  Damage to the DNA that does not produce a DSB is re-
paired by the BER, NER, or MMR pathways. NER is capa-
ble of recognizing and repairing a large variety of DNA he-
lix-distorting lesions, including UV induced pyrimidine di-
mers and DNA intrastrand cross-links [14, 15]. Two distinct 
processes of NER, global genomic NER (GG-NER) and 
transcription coupled NER (TC-NER), are involved in dam-
age repair of transcriptionally silenced or active areas of the 
genome, respectively. The mechanisms of these two path-
ways are similar except for damage recognition. MMR, 
which occurs mostly at the post-replication stage, is respon-
sible for repairs of mismatches and small stranded DNA 
loops that are important in stabilizing the genome. The 
MMR mechanism is also believed to interact directly with 
NER and homologous recombination [16, 17]. Defects in 
these DNA repair mechanisms produce gene mutations, 
which are associated with several syndromes, such as 
xeroderma pigmentosum (XP), and can significantly increase 
the possibility of oncogenesis [18, 19]. Recent studies have 
presented increasing evidence that these non-DSB repair 
mechanisms are highly involved in DSB repair. These find-
ings, which are the focus of this review, have dramatically 
widened the current knowledge of DSB repair mechanisms 
and have indicated that the various DNA repair pathways are 
not separated, but well interlinked. 
NER PROTEINS IN DSB REPAIR 
  More than 30 proteins are required in a successful NER 
process to finish a series of tasks including damage recogni-
tion, DNA duplex opening, damaged DNA strand cutting, 
DNA synthesis, and strand ligation. Helical distortion of the 
DNA duplex and modification of the DNA chemistry are the 
common features of lesions recognized by the NER pathway 
[20]. In GG-NER, the XPC protein complex is responsible 
for the initial detection of damaged DNA [21], whereas, in 
TC-NER, the displacement of a stalled RNA Polymerase 
complex is aided by the CSA and CSB proteins in order to 
allow the NER proteins to access the damaged site [22]. 
There is substantial evidence that suggests three NER com-
plexes, namely XPC/HR23B, XPA/RPA and ERCC1/XPF, 
may actively be involved in DSB repair. Genes associated 
with the NER pathway, such as XPC, have been found to be 
consistently up-regulated by IR [23, 24]. It has been found 
that the XPC defect affects the expression of some DSB re-
pair genes induced by cisplatin, which causes DNA cross-
links [25]. Various reports have suggested that XPC defects 
elicit impaired cellular responses to IR, indicating the possi-
ble role of XPC in DSB repair. Recently, Biard and his re-
search group reported that long-term suppression of the XPC 
gene in HeLa cells changed DNA repair capacity by affect-
ing NHEJ DNA repair, although the expression of NHEJ 
proteins were not altered [26]. The deficiency of XPC re-
sulted in 30-40% reduction of NHEJ efficiency with de-
creased intramolecular joined products, thus affecting the 
cellular response
 to acute high dose IR-induced
 DNA dam-
age. XPC
 knock-down (XPC
KD) cells also exhibited an en-
hanced sensitivity to etoposide (VP16), a topoisomerase II 
inhibitor that creates DSBs through the progression of DNA 
replication forks [26].
 Moreover, both XPC
KD and HR23B
KD 
HeLa cells displayed intolerance to high dose gamma rays, 
showing increased cell cycle arrest and decreased survival 
based on clonogenic assays [27]. Furthermore, an XPC defi-
cient cell line
  derived from an XP-C patient also showed 
disrupted cellular response to gamma rays [28]. To date, 
more than a hundred polymorphic variants in the XPC gene 
have been identified. Among the three most common poly-
morphisms, Ala499Val (C-T), PAT (-/+) and Lys939Gln (A-
C), Lys939Gln (A-C) has been reported to be associated with 
reduced DNA damage repair capacity in human peripheral 
blood leukocytes (PBLs) after gamma ray exposure [29, 30]. 
This may explain the increased risk of malignancies associ-
ated with this variant allele of XPC [31-33]. These results 
reveal that the XPC protein is involved in DSB repair and 
may act in a much broader cellular mechanism
 than initiation 
of GG-NER alone.  
  Although the initial recognition step is different between 
the GG- and TC-NER pathways, the subsequent step in both 
pathways is essentially identical with the binding of the 
XPA/RPA complex to the injury site that supports damage 
recognition and subsequent repair machinery recruitment 
[34, 35]. First identified as a single-strand DNA binding pro-
tein in the 1990s, heterotrimer RPA consists of 70 (RPA1), 
34 (RPA2) and 14 kD subunits and is found to be involved in 
diverse DNA metabolic activities and the NER pathway to 
maintain genomic stability through both in vivo and in vitro 
approaches [36, 37]. Later studies have suggested that RPA 
plays a role in DSB repair and in almost every DNA repair 
mechanism. RPA participates in these processes through its 
interaction with other proteins and its strong affinity for sin-
gle-stranded DNA (ssDNA) [37, 38]. Recombinant RPA was 
first found to have a physical interaction with RAD52 pro-
teins in vitro and in insect cells [39]. RPA also colocalized 
with RAD51 to form foci in IR irradiated exponentially 
growing mouse fibroblasts [40]. Further studies have shown 
that the phosphorylated form of RPA2 has cellular interac-
tion with RAD52, as well as ATR in response to genotoxic 
insults [41]. In various human cells receiving IR treatment, 
RPA2 has been found to relocate to form distinct nuclear 
foci, colocalized with gamma-H2AX at the sites of DNA 
damage in a time-dependent manner. This reaction was 
phosphatidylinositol-3 (PI-3) kinase and ATM dependent. 
The time course of RPA and gamma-H2AX foci formation 
correlated well with the DSB repair activity analyzed by 
neutral comet assay [42]. The depletion of RPA by small 
interfering RNA (siRNA) elevated the frequencies of IR-
induced micronulcei (MN) and apoptosis [42].  
  Many studies have also been conducted on other species, 
such as Saccharomyces cerevisiae (S. Cerevisiae), and find 
that RPA has a direct role in homologous recombination 
repair, which is essential for the repair of DNA DSBs in mi-
totic and meiotic cells. RPA directly binds to RAD52 upon 
replication stress and the depletion of the RPA protein inhib-
its the formation of RAD51 nuclear foci in the presence of 
persistent unrepaired DNA DSBs led by hydroxyurea-
induced replication stalling [43]. After decades of various 
studies, Kowalczykowski’s group has proposed a mechanism 
of second-end capture as one of the DSB repair steps, which 
involves RPA as the initial protein binding to the 3’ ssDNA 
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showed that NHEJ proceeded faster and to higher levels of 
completion in the presence of recombinant RPA protein, 
although this DSB rejoining was apparently not RPA de-
pendent. The results suggest that in addition to its role in 
homologous recombination, RPA may also have a supportive 
role in some forms of non-homologous end-joining [46]. In 
our earlier study, the loss of RPA1 expression impaired DSB 
repair, as shown by increased MN formation, indicating the 
important function of RPA during the process of DNA repair 
[47].  
  It is believed that XPA is involved in DNA damage rec-
ognition and also in the recruitment of other NER factors to 
the DNA damage site to form dual incision complexes 
through protein-protein interactions [48, 49]. It has been 
shown that XPA has high affinity to ds-ssDNA junctions and 
interstrand crosslink lesions (ICLs), the common DNA in-
termediate structures in many DNA metabolic pathways, 
suggesting the additional role of XPA beyond the NER 
pathway [50, 51]. In our former study, gamma irradiated 
cells with suppressed expression of XPA exhibited a pheno-
type of elevated cell cycle progression and higher incidence 
of MN, as well as a higher frequency of chromosome trans-
locations, indicating involvement of XPA in the regulation 
of DSB repair [47]. This may explain why, in addition to XP 
syndrome, a higher incidence of spontaneous tumorigenesis 
has been observed in the Xpa
-/- mice compared to wild type 
controls [52, 53].  
  In the next step of the NER process, the endonucleases 
XPG and ERCC1 (Excision Repair Cross-Complementing 
Group-1)/XPF are recruited to the damaged site and cleave 
one strand of the DNA at positions 3' and 5' to the damage, 
respectively. This step generates a displaced strand of about 
30 oligonucleotides in order to proceed with the gap repair 
synthesis [54-56]. XPF has been shown to be physically in-
volved in psoralen and mitomycin C induced ICL repair [57, 
58], indicating that the ERCC1–XPF complex may have 
functions in cellular processes other than the NER pathway, 
such as DNA recombination and double-strand break repair. 
The homolog proteins of ERCC1-XPF in various species do 
facilitate DSB repair and mediate the resistance to IR [59-
61]. Similar findings have provided substantial evidence that 
the ERCC1-XPF complex mediates DSB repair in both nor-
mal mammalian cells and mouse embryonic stem cells. 
ERCC1-XPF deficient murine and human fibroblast cells 
showed hypersensitivity to IR similar to cells defective in 
HR-mediated or NHEJ DSB repair [62]. Furthermore, the 
involvement of ERCC1-XPF may be Ku independent since 
ERCC1
-/- KU86
-/- fibroblasts were more sensitive to gamma 
irradiation compared to single mutants and Ercc1
-/-  DNA-
PKs
-/- double mutants, causing a significant persistence of 
gamma H2AX foci and accumulation of chromosomal aber-
rations. It suggests that ERCC1-XPF may be an alternative 
DNA end-rejoining factor, but not be a part of traditional 
NHEJ machinery because there is no evidence of severe 
NHEJ deficiency in Ercc1
-/-, Xpf
-/- mice or humans with XPF 
deficiency [63]. However, Ercc1/Xpf mutant mice did show 
hypersensitivity to gamma irradiation, establishing an essen-
tial role for ERCC1-XPF in protecting against DSBs in vivo. 
The XPF deficiency has been shown to be responsible for a 
pronounced genomic instability phenotype with suppressed 
gene conversions in the Chinese hamster cell line UV41 
[63]. It suggests that single strand annealing (SSA) may be 
the alternative pathway for HR or NHEJ repair of DSBs, 
which is ERCC1-XPF dependent. SSA was first identified in 
S. Cerevisiae [64]. The DSB lying between two repeated 
sequences can stimulate the deletion between the repeats, 
annealing of these two complimentary sequences, and DNA 
synthesis and ligation through this SSA pathway [64, 65]. 
Many DSB repair proteins as well as several mismatch repair 
proteins, such as Rad52, RPA and MSH2, are involved in the 
SSA pathway [65-67]. A recent report from Helleday’s 
group has provided evidence that ERCC1-XPF may mediate 
the repair of DSBs through both SSA and gene conversion 
pathways in homologous recombination [68].  
MMR PROTEINS IN DSB REPAIR 
  The MMR system is responsible for the post-replicative 
repair of mismatches and small single-strand DNA loops. 
There are several proteins engaged in the MMR process, 
including two different heterodimeric complexes of MSH2-
MSH3 and MSH2-MSH6 with different misrepair recogni-
tion specificity. Another heterodimeric complex of MLH1-
PMS2 interacts with MSH complexes and replication factors. 
Excision and resynthesis of the misrepaired strand are per-
formed by a number of proteins, such as PCNA and RPA. 
Most importantly, the MMR pathway is believed to serve as 
one of the most critical genome surveillance systems to 
maintain faithful DNA replication and transmission of accu-
rate genetic information [69-71]. It has been suggested that 
MMR proteins are broadly involved in various aspects of 
DNA metabolism, such as the DNA damage response and 
homologous recombination which mediate DSB repair, 
rather than DNA mismatch correction alone. Defects in this 
system, such as mutations in MSH2 and MLH1, may be in-
volved in the process of oncogenesis and have been reported 
to be associated with various cancers, including hereditary 
nonpolyposis colorectal cancer [72, 73].  
 In  S. Cerevisiae, homologous recombination initiated by 
DSBs proceeds through two distinct pathways, gene conver-
sion and SSA [74, 75]. In both cases, any presenting nonho-
mologous DNA at the ends must be removed before new 
DNA synthesis and ligation can occur and this event depends 
not only on the NER endonuclease RAD1/RAD10 but also 
on MSH2 and MSH3 [76-78]. Defects in MSH2 and MSH3 
have been shown to impair the removal of nonhomologous 
ends in both DSB-induced gene conversion and SSA [79]. It 
has been confirmed that S. cerevisiae MSH2-MSH3 specifi-
cally binds branched DNA substrates containing 3' single-
stranded DNA and the release of MSH2-MSH3 is ATP-
dependent. This binding of MSH2-MSH3 to the double-
strand/single-strand junction enables the change of DNA 
conformation to an open position [79]. Researchers further 
confirmed that MSH2-mutant embryonic stem (ES) cells fail 
to correct mismatched heteroduplex DNA (hDNA) that is 
formed adjacent to the DSB during gene conversion repair of 
DSBs although cells seemed to be able to repair DSBs effi-
ciently. This suggests that gene conversion repair of DSBs in 
mammalian cells involves mismatch repair proteins [80]. 
Another study showed that MSH2-deficient colorectal carci-
noma cell lines failed to accurately repair enzyme restricted 
plasmid DNA DSBs mediated by gene conversion [81]. 
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only 8% of MSH2 deficient cells presented precise gene 
conversion products, resulting in significant increase of rear-
ranged repair [81]. Moreover, a recent study by Waldman’s 
research group has verified that MSH2 deficient CHO cells 
produce less precise gene conversion products, although the 
overall frequency of DSB-induced recombination was in-
creased [82]. All these reports suggest that MSH2 modulates 
homologous recombination. In response to genotoxic insults, 
Msh2
-/- murine embryonic fibroblasts and Msh2-deficient 
mouse colorectal carcinoma cells were hypersensitive to 
CPT-induced chromosomal damage and cell death [83]. In 
the absence of MSH2, the recruitment of RAD51 to the 
damage sites is delayed [83]. X-ray irradiated MSH2-defi- 
cient cells showed the absence of MRE11 or RAD51 relocal-
ization and reduced cell survival, which were associated with 
increased chromosomal damage in G2 phase cells [84]. In 
addition to altered HR associated with MSH2 deficiency, 
loss of MSH2 may also influence the NHEJ pathway at the 
step of pairing of terminal DNA tails [85]. These impaired 
responses of MSH2-deficient cells to genotoxic insults indi-
cate the involvement of MSH2 in the repair of DSBs.  
  MLH1, another protein involved in MMR repair, has also 
been suggested to be involved in the DSB repair pathway 
and reported to be required in the NF-kappaB activation after 
treatment with both CPT and X rays [86]. Although Mlh1
-/- 
mouse embryonic fibroblasts had similar NHEJ efficiency to 
that of control cells to repair an I-SceI restricted plasmid that 
is stably transfected into the cells, the incidences of deletion 
associated with NHEJ events were dramatically higher in 
wild-type cells. This indicates that MLH1 modulates error-
prone NHEJ by inhibiting the annealing of DNA ends con-
taining noncomplementary base pairs [87]. Furthermore, the 
influence of MLH1 on IR-induced autosomal mutations has 
been studied in a mouse Mlh1
-/- kidney cell line. A high fre-
quency of IR induced mutations was found in Mlh1
-/- cells 
due to increased crossover events of mitotic recombination, 
suggesting that MLH1, or MMR may serve as a modulator in 
mitotic HR repair [88]. Mlh1
-/- mice, which have been used 
as a model of hereditary non-polyposis colorectal cancer 
(HNPCC), spontaneously developed gastrointestinal tumors 
(GIT) and thymic lymphomas by 48 weeks. X-ray irradiation 
of Mlh1 knockout mice has been found to accelerate the car-
cinogenesis process of GIT [89]. Our data in a previous 
study showed that the expression of MLH1 was induced by 
IR, and the loss of MLH1 expression not only elevated cell 
cycle progression but also increased the yield of IR-induced 
chromosomal translocations, suggesting that this gene, in-
volved mostly in MMR, may play a role in DSB repair and 
cell cycle regulation [47]. 
NER AND MMR PROTEINS IN DNA DAMAGE-
INDUCED G2-CELL CYCLE ARREST  
  The DNA double strand break repair and checkpoint con-
trol are the two major mechanisms that function to prevent 
chromosomal instability following exposure to DSB induc-
ers, such as IR. ATM has been identified as a critical factor 
for the initiation of checkpoint pathways [90]. The substrates 
of ATM kinase are broad, including many cell cycle control 
proteins participating in G1/S and G2/M checkpoint path-
ways [2, 91-95]. It is still poorly understood how the initial 
DNA lesion signals the initiation of checkpoints, and how 
the successful DNA repair allows the release of cells through 
the checkpoints. Recent studies have suggested that DNA 
repair proteins may be involved in cell cycle signaling and 
act beyond their repair roles. DNA damage repair processing 
by repair proteins may be required for recruiting checkpoint 
proteins to damaged DNA to activate checkpoints. MMR 
and NER have both been shown to not only regulate DSB 
repair, but also to be involved in IR induced cell cycle arrest, 
especially the G2/M checkpoint. In diploid growth cells, two 
different proposed G2/M arrest mechanisms may be present 
in mammalian cells [96]. The G2/M checkpoint that occurs 
early and transiently after IR is ATM dependent, and pre-
vents cells in G2 phase at the time of irradiation from pro-
gressing into mitosis. The next stage is G2/M accumulation, 
which is measurable several hours after IR. This later event 
of G2/M arrest is dose dependent, but is ATM independent 
and not affected by the early G2/M checkpoint process (97). 
An imperfect G2/M checkpoint has been shown to contribute 
to chromosome instability in irradiated S and G2 phase cells 
[97, 98]. 
  In the NER pathway, the evidence implicating XPC/ 
HR23B and XPF/ERCC1 complexes in cell cycle regulation 
is very limited with only one report showing that XPC may 
be associated
 with the centrosomal protein centrin 2, indicat-
ing a possible linkage of XPC to cell
 division [99]. However, 
RPA and XPA proteins, which form a complex, have shown 
their potential roles of linking DNA damage detection and 
initiation of the G2/M checkpoint. S. cerevisiae cells with a 
single unrepairable DSB exhibit long, but transient arrest at 
G2/M. This DSB-induced arrest has been shown to be sup-
pressed by RPA mutation, suggesting that RPA is one of the 
key regulators in the DNA damage-induced G2/M check-
point [100]. In mammalian cells, RPA2, the 32kD subunit of 
RPA, is phosphorylated in the S and G2 phase of cell cycle 
through the CDC2 kinase [101] and hyperphosphorylated in 
cellular responses to DNA damage through ATM and DNA-
PK [102], which is an essential step in chromosomal DNA 
repair [103]. Distinct phosphorylated forms of RPA2 have 
been identified in different cell-cycle stages and in response 
to DNA damage [102, 104]. The phosphorylated form of 
RPA2 in mitotic cells has been reported to exhibit less bind-
ing efficiency to double-stranded DNA and altered interac-
tion with several DNA replication and repair proteins. In 
vitro, this type of phosphorylated RPA showed decreased 
binding to ATM, DNA pol alpha, and DNA-PK compared to 
unphosphorylated recombinant RPA [105]. In contrast, hy-
perphosphorylated RPA showed a high affinity for damaged 
duplex DNA in response to DNA damage [105]. Further 
studies have verified that RPA2 phosphorylated by cyclin B-
CDC2 during the prometaphase of mitosis stimulates RPA2 
to become hyperphosphorylated in response to mitotic DNA 
damage caused by bleomycin treatment, which causes sin-
gle- and double-stranded breaks in DNA [106]. Mutation in 
RPA2 causing the lack of both CDC2 phosphorylation sites 
significantly suppressed the mitotic release of DNA dam-
aged cells into G1 phase, thus decreasing cell viability [106]. 
These results demonstrate that RPA hyperphosphorylation 
regulates the cell cycle arrest induced by DNA strand breaks 
[106, 107].  
  In addition to RPA2, the depletion of RPA1, the largest 
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malian cells. Cells lacking RPA1 have slower S phase pro-
gression with a G2/M arrest, leading to phosphorylation of 
CHK2 and activation of p21 expression in human embryonic 
kidney and Hela cells [108, 109]. In response to camptothe-
cin (CPT) and etoposide (ETP) induced DNA strand breaks, 
cells depleted of RPA1 showed a substantially accumulated 
number in S phase compared with G2/M arrest in wild type 
cells, which is consistent with the defect in DNA replication 
caused by RPA1 deficiency [110]. Furthermore, CPT and 
ETP treated RPA1-t11 Hela cells, which bear mutations at 
R41 and Y42, progressed into G1 phase rather than becom-
ing arrested in G2/M phase. This suggests the critical func-
tion of the N terminal of the RPA1 containing DBD-F do-
main in cell cycle regulation and DNA repair [110]. This 
result is consistent with the defect of the G2/M checkpoint 
reported in rfa1-t11 mutant yeast cells, which also bear a 
mutation in RPA [111]. 
  The strong interaction of XPA with RPA suggests XPA 
as another candidate contributing to the linkage of DNA re-
pair to cell cycle checkpoint. It has been shown that the yeast 
homolog of the human XPA protein, Rad14p, physically 
interacts with checkpoint protein Ddc1 [112]. Several studies 
have revealed that XPA may be involved in the cell cycle 
checkpoint induced by UV-generated lesions. An XPA de-
fect abolished the phosphorylation of CHK1 and p53 in both 
G1 and G2 checkpoint responses to UV in primary human 
fibroblasts [113]. In UV irradiated cells, the modulation and 
phosphorylation of XPA has been showed to be ATR de-
pendent. The XPA deficient cells with an XPA-S196 phos-
phorylation site mutation showed higher UV sensitivity. 
Moreover, cells with substituted XPA having Aspartic acid 
at S196 to mimic persistent phosphorylation had an in-
creased cell survival rate compared with wild type cells after 
UV treatment. Therefore, the phosphorylation at S196 of 
XPA may be significant to the ATR-dependent checkpoint 
pathway in human cells [114]. Another recent report has 
revealed that the ATR signaling pathway is also compro-
mised in XPA-deficient cells during S phase, as shown by 
defects in UV-induced phosphorylation of CHK1 and RPA 
using various cell lines. This lesion recognition function of 
XPA may be sufficient for ATR-mediated S-phase check-
point activation since none of XPC-, CSB-, XPF- and XPG-
deficient cells have impaired S-phase responses [115]. XPA 
has also been found to interact with a novel centrosomal pro-
tein, CEP164, at amino acids 4-97 of XPA [116]. CEP164 
has been identified as a chromatin binding mediator protein 
that interacts with both ATR and ATM and is phosphory-
lated upon replication stress, UV radiation, and IR. The de-
fect of this protein significantly reduces DNA damage-
induced phosphorylation, such as phosphorylation of RPA, 
H2AX, MDC1, CHK2, and CHK1, and dramatically affects 
the G2/M checkpoint and nuclear divisions. This protein, 
therefore, has critical roles in both DNA damage induced 
checkpoint and repair [117]. Upon UV damage, XPA is re-
quired to recruit CEP164 to the damage sites. This activity 
was abolished by XPA mutation in XPA-deficient fibro-
blasts. Furthermore, XPA deficient cells showed impaired 
UV-induced CHK1 phosphorylation that may explain in-
creased cell survival upon UV damage [116]. These findings 
provide further evidence that XPA and its interactants may 
mediate a critical juncture between checkpoint pathways and 
repair systems. Not only UV induced DNA damage, but also 
cisplatin induced G2/M arrest was impaired in XPA deficient 
fibroblast cells compared with wild type cells [118]. In our 
previous report, gamma irradiated XPA
KD cells showed in-
creased cell cycle progression as a significantly increased 
percentage of bi-nucleated cells compared with irradiated 
control cells after cytoclasin B treatment, which arrests cells 
at the stage between mitosis and division [47]. 
  In the MMR pathway, studies have shown that both 
MSH2 and MLH1 are involved in G2 phase cell cycle pro-
gression, suggesting that MMR-mediated cell cycle delay 
may be important for its function of proofreading the re-
paired DNA lesions prior to chromosome segregation to pre-
vent passing critical lesions to daughter cells [119]. The 
MLH1 protein was reported to be involved in G2-M cell 
cycle checkpoint arrest induced by 5-flurouracil (5-FU) ex-
posures, which resulted in DNA base damage and mispair 
lesions [120]. A recent study has demonstrated that MMR-
dependent G2 arrest responses are dependent on a human 
MLH1/c-ABL/GADD45alpha signaling pathway [121]. The 
P53 pathway may be involved as well in MMR-dependent 
G2 arrest since it has been also shown that MLH1 has p53-
response elements within the first intron and is responsive to 
p53 activation in normal human fibroblasts [122]. Thus, 
MLH1 may function beyond its MMR role as both a primary 
sensor to DNA damage and a critical interlink between DNA 
repair and cell-cycle arrest. IR treatment also generates DNA 
mismatches directly as well as from the DSB NHEJ repair 
process that is error prone [123]. Nevertheless, DSB repair 
involves MMR proteins, suggesting that MMR may also be 
the mediator in the DSB induced G2/M checkpoint. It has 
been demonstrated that both MLH1 and MSH2 deficient 
human colon carcinoma cells and murine primary embryonic 
fibroblasts display higher tolerance to gamma radiation in-
duced DNA damage associated with reduced p53 dependent 
responses [124]. The deficient cells also exhibit a deficiency 
in the G2-M cell cycle checkpoint after IR exposure, as 
shown by fewer cells and a shorter period in G2/M arrest 
[124]. These findings have been further confirmed in human 
ovarian, endometrial and another colorectal cancer cell line 
with or without ectopically expressing MSH2, showing that 
the defect affects both X-ray and UVB induced G2 cell cycle 
arrest [84, 125]. Although the level of phosphorylated CDC2 
(phospho-CDC2) was increased in both MMR-proficient and 
-deficient cell lines after IR, the amount of phospho-CDC2 
rapidly decreased in MLH1 or MSH2-deficient cell lines 
associated with elevated progress from G2 arrest through M 
phase. This MMR mediated G2 cell cycle regulation may act 
through a decreased CDC2 phosphorylation, which upregu-
lates CDC2 kinase activity [126] and enables cells to bypass 
repair lesions and being released from G2 phase. These dif-
ferences in IR-induced G2 arrest between MMR-proficient 
and -deficient cells were found regardless of the original cell 
cycle stage, indicating that the regulatory effect of MMR on 
IR induced G2/M checkpoint arrest is dramatic [126].  
SUMMARY 
  In response to DNA damaging agents, complex damage 
response pathways are activated in mammalian cells. These 
pathways regulate a series of known post-insult responses: 
A. surveillance of DNA lesions; B. induction of cell cycle Involvement of Nucleotide Excision and Mismatch Repair Mechanisms  Current Genomics, 2009, Vol. 10, No. 4    255 
checkpoint; C. activation of DNA repair; D. maintenance of 
cell cycle arrest, and removal of cells with unrepaired DNA 
damage through apoptosis; E. proofreading and repair of 
minor incorrect repaired or repair intermediate lesions; and 
F. cellular signaling leading to either cell cycle progression 
or apoptosis (Fig. 1). Although DSB repairs utilize mainly 
the HR and NHEJ repair machinery, a successful DSB repair 
process depends on precise and timely post-insult responses 
from A to F, and thus involves a systematically coordinated 
cellular network. Recent studies have confirmed that non-
DSB repair mechanisms, such as NER, MMR and cell cycle 
regulation are highly involved in DSB repairs. These find-
ings have revealed previously unrecognized roles for various 
non-DSB repair genes, in that a successful DSB repair re-
quires both DSB repair machinery and non-DSB repair sys-
tems. The involvement of NER and MMR proteins such as 
RPA, XPA, MLH1 and MSH2, in both the cell cycle regula-
tion and DSB repair, underline the importance of these pro-
teins beyond their original pathways. These proteins regulate 
and maintain cell cycle arrest by either direct or indirect in-
teraction with other cell cycle control proteins. They may 
also play a role in proofreading of the repaired DNA and 
sending signals for the repaired cells to progress through the 
checkpoint. 
  The NER and MMR proteins significantly influence the 
success of DSB repair through the following three steps: 
first, both NER and MMR physically facilitate HR/NHEJ 
machinery, especially in the processing of intermediates dur-
ing DSB repair; second, the ability of recognizing the DNA 
signal strand and various small DNA structure changes may 
allow NER and MMR to participate in primary damage sur-
veillance; and last but not least, several NER and MMR pro-
teins have critical roles in signaling between primary damage 
reorganization, induction of cell cycle checkpoint and bridg-
ing, proofreading and permitting cell cycle progression (Fig. 
1). 
  Effective repair of DSBs is of great importance for the 
maintenance of genome stability and prevention of carcino-
genesis. Incorrectly repaired lesions potentially generate 
mutations/recombinations that are prone to induce activation 
of proto-oncogenes, inactivation of tumor suppressor genes 
or loss of heterozygosity which can lead to carcinogenesis. 
Therefore, in response to DSB damage, the appropriate NER 
and MMR involvement is required. Failure to do so could 
change the outcome of post-repair scenarios: cell cycle arrest 
versus apoptosis; repaired, unrepaired, or misrepaired DNA; 
or even carcinogenesis. 
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